Shares of The Descartes Systems Group Inc. (NASDAQ:DSGX – Get Free Report) (TSE:DSG) have received a consensus rating of “Moderate Buy” from the twelve brokerages that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and eight have assigned a […]

Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) have been given an average rating of “Buy” by the nine research firms that are presently covering the stock, MarketBeat reports. Eight analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […]

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued a report on the stock […]

Shares of AppLovin Co. (NASDAQ:APP – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and ten have issued a buy recommendation on the […]

Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) have earned a consensus recommendation of “Buy” from the six research firms that are covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have issued ratings on the stock in the […]

TD Cowen began coverage on shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) in a report published on Monday morning, MarketBeat Ratings reports. The brokerage issued a buy rating on the stock. ORKA has been the subject of several other research reports. Jefferies Financial Group assumed coverage on Oruka Therapeutics in a report on Friday, […]